News & Articles

Leading discovery operations worldwide, new VP brings 30 years of experience and a proven track record of success to the role

Peak Proteins' expertise in protein crystallography will enhance Sygnature Discovery’s fragment screening and analysis activities as well as its structure-based drug design capabilities

Automated sample storage for multi-customer, multi-year storage HTS relationships

In this newly created role, he will work alongside Dr Paul Clewlow, Senior VP, Business Development and Executive Board Director

Deal enables a wider suite of pre-clinical testing services in oncology